spacer
spacer

PDBsum entry 1jlq

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transferase PDB id
1jlq

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
534 a.a. *
405 a.a. *
Ligands
SBN
* Residue conservation analysis
PDB id:
1jlq
Name: Transferase
Title: Crystal structure of HIV-1 reverse transcriptase in complex with 739w94
Structure: HIV-1 rt, a-chain. Chain: a. Fragment: p66. Engineered: yes. HIV-1 rt, b-chain. Chain: b. Fragment: p51. Engineered: yes
Source: HIV-1 m:b_hxb2r. Organism_taxid: 11706. Strain: hxb2 isolate. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
Biol. unit: Dimer (from PQS)
Resolution:
3.00Å     R-factor:   0.219     R-free:   0.267
Authors: J.Ren,D.I.Stuart,D.K.Stammers
Key ref: J.H.Chan et al. (2001). 2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1. J Med Chem, 44, 1866-1882. PubMed id: 11384233 DOI: 10.1021/jm0004906
Date:
16-Jul-01     Release date:   22-Aug-01    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
534 a.a.*
Protein chain
Pfam   ArchSchema ?
P04585  (POL_HV1H2) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
405 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: Chains A, B: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 3: Chains A, B: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: Chains A, B: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: Chains A, B: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 6: Chains A, B: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 7: Chains A, B: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/jm0004906 J Med Chem 44:1866-1882 (2001)
PubMed id: 11384233  
 
 
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.
J.H.Chan, J.S.Hong, R.N.Hunter, G.F.Orr, J.R.Cowan, D.B.Sherman, S.M.Sparks, B.E.Reitter, C.W.Andrews, R.J.Hazen, M.St Clair, L.R.Boone, R.G.Ferris, K.L.Creech, G.B.Roberts, S.A.Short, K.Weaver, R.J.Ott, J.Ren, A.Hopkins, D.I.Stuart, D.K.Stammers.
 
  ABSTRACT  
 
A series of 2-amino-5-arylthiobenzonitriles (1) was found to be active against HIV-1. Structural modifications led to the sulfoxides (2) and sulfones (3). The sulfoxides generally showed antiviral activity against HIV-1 similar to that of 1. The sulfones, however, were the most potent series of analogues, a number having activity against HIV-1 in the nanomolar range. Structural-activity relationship (SAR) studies suggested that a meta substituent, particularly a meta methyl substituent, invariably increased antiviral activities. However, optimal antiviral activities were manifested by compounds where both meta groups in the arylsulfonyl moiety were substituted and one of the substituents was a methyl group. Such a disubstitution led to compounds 3v, 3w, 3x, and 3y having IC50 values against HIV-1 in the low nanomolar range. When gauged for their broad-spectrum antiviral activity against key non-nucleoside reverse transcriptase inhibitor (NNRTI) related mutants, all the di-meta-substituted sulfones 3u-z and the 2-naphthyl analogue 3ee generally showed single-digit nanomolar activity against the V106A and P236L strains and submicromolar to low nanomolar activity against strains E138K, V108I, and Y188C. However, they showed a lack of activity against the K103N and Y181C mutant viruses. The elucidation of the X-ray crystal structure of the complex of 3v (739W94) in HIV-1 reverse transcriptase showed an overlap in the binding domain when compared with the complex of nevirapine in HIV-1 reverse transcriptase. The X-ray structure allowed for the rationalization of SAR data and potencies of the compounds against the mutants.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20942836 R.Hu, F.Barbault, F.Maurel, M.Delamar, and R.Zhang (2010).
Molecular dynamics simulations of 2-amino-6-arylsulphonylbenzonitriles analogues as HIV inhibitors: interaction modes and binding free energies.
  Chem Biol Drug Des, 76, 518-526.  
19691465 B.Hemmateenejad, R.Sabet, and A.Fassihi (2009).
Quantitative structure-activity relationship studies on 2-amino-6-arylsulfonylbenzonitriles as human immunodeficiency viruses type 1 reverse transcriptase inhibitors using descriptors obtained from substituents and whole molecular structures.
  Chem Biol Drug Des, 74, 405-415.  
18676450 J.D.Bauman, K.Das, W.C.Ho, M.Baweja, D.M.Himmel, A.D.Clark, D.A.Oren, P.L.Boyer, S.H.Hughes, A.J.Shatkin, and E.Arnold (2008).
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design.
  Nucleic Acids Res, 36, 5083-5092.
PDB code: 3dlk
17949071 G.Barreiro, C.R.Guimarães, I.Tubert-Brohman, T.M.Lyons, J.Tirado-Rives, and W.L.Jorgensen (2007).
Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.
  J Chem Inf Model, 47, 2416-2428.  
16911530 J.Ren, C.E.Nichols, A.Stamp, P.P.Chamberlain, R.Ferris, K.L.Weaver, S.A.Short, and D.K.Stammers (2006).
Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
  FEBS J, 273, 3850-3860.
PDB codes: 2hnd 2hny 2hnz
16525561 M.P.Freitas (2006).
MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners.
  Org Biomol Chem, 4, 1154-1159.  
16508186 T.Maruyama, S.Kozai, Y.Demizu, M.Witvrouw, C.Pannecouque, J.Balzarini, R.Snoecks, G.Andrei, and E.De Clercq (2006).
Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives.
  Chem Pharm Bull (Tokyo), 54, 325-333.  
15612053 B.M.Trost, C.Pissot-Soldermann, and I.Chen (2005).
A short and concise asymmetric synthesis of hamigeran B.
  Chemistry, 11, 951-959.  
16163450 J.L.Medina-Franco, A.Golbraikh, S.Oloff, R.Castillo, and A.Tropsha (2005).
Quantitative structure-activity relationship analysis of pyridinone HIV-1 reverse transcriptase inhibitors using the k nearest neighbor method and QSAR-based database mining.
  J Comput Aided Mol Des, 19, 229-242.  
15249669 J.D.Pata, W.G.Stirtan, S.W.Goldstein, and T.A.Steitz (2004).
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.
  Proc Natl Acad Sci U S A, 101, 10548-10553.
PDB code: 1tv6
15229890 M.Barbany, H.Gutiérrez-de-Terán, F.Sanz, and J.Villà-Freixa (2004).
Towards a MIP-based alignment and docking in computer-aided drug design.
  Proteins, 56, 585-594.  
15544453 N.Sluis-Cremer, N.A.Temiz, and I.Bahar (2004).
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.
  Curr HIV Res, 2, 323-332.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer